0000899243-21-026782.txt : 20210630
0000899243-21-026782.hdr.sgml : 20210630
20210630180049
ACCESSION NUMBER: 0000899243-21-026782
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210628
FILED AS OF DATE: 20210630
DATE AS OF CHANGE: 20210630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COOPER GRAHAM K
CENTRAL INDEX KEY: 0001396943
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39208
FILM NUMBER: 211063098
MAIL ADDRESS:
STREET 1: C/O RECEPTOS, INC.
STREET 2: 10835 ROAD TO THE CURE, SUITE 205
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Beam Therapeutics Inc.
CENTRAL INDEX KEY: 0001745999
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-327-8775
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-28
0
0001745999
Beam Therapeutics Inc.
BEAM
0001396943
COOPER GRAHAM K
C/O BEAM THERAPEUTICS INC.,
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2021-06-28
4
M
0
12045
17.00
A
12045
D
Common Stock
2021-06-28
4
S
0
5787
105.37
D
6258
D
Common Stock
2021-06-28
4
S
0
3196
106.28
D
3062
D
Common Stock
2021-06-28
4
S
0
1162
107.22
D
1900
D
Common Stock
2021-06-28
4
S
0
900
108.30
D
1000
D
Common Stock
2021-06-28
4
S
0
1000
109.39
D
0
D
Stock Option (Right to Buy)
17.00
2021-06-28
4
M
0
12045
0.00
D
2030-02-05
Common Stock
12045
19175
D
The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.98, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.77, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.60, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.12 to $108.60, inclusive.
The option vests as to one third on the first anniversary of the of the vesting commencement date, February 5, 2020, and at a rate of 4.17% each month thereafter until the option is fully vested.
By: /s/ Christine Bellon, Attorney-in-fact
2021-06-30